Breast Cancer 3D – Chicago, IL
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.
This case-based live activity will cover the treatment and management of patients with multiple sclerosis (MS).
This live activity will cover the treatment and management of patients with Metastatic, Hormone-Receptor Positive, HER-2 Negative Breast Cancer.